The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
Open accessAbstract
The rising incidence of obesity and metabolic diseases such as diabetes mellitus and cardiovascular disease in adolescents and young adults is of grave concern. Recent studies favor a role of lifestyle factors over genetics in the perpetuation of inflammation, insulin resistance and oxidative stress, which are pathophysiologic processes common to the above diseases; furthermore, the importance of dietary factors in addition to calories and physical activity in these processes is being increasingly recognized. Advanced glycation end products (AGEs) belong to a category of dietary oxidants which have been implicated in the pathogenesis of inflammation, oxidative stress, insulin resistance, β-cell failure and endothelial dysfunction. This paper reviews the studies of AGEs with a focus on their role in cardiometabolic disease in children. A Medline search was performed using the key words ‘childhood obesity', ‘metabolic syndrome' and ‘advanced glycation end products'. Articles published in English between 1975 and 2015 and their references were reviewed. While most studies were performed in adults, a few studies also demonstrated a role of AGEs in obesity and associated cardiometabolic comorbidities in the younger population. Available evidence suggests an involvement of AGEs in the pathogenesis of adiposity and β-cell failure in children. Potential areas for further research to investigate underlying mechanisms are proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, Y., Sheu, M., Tsai, K., Yang, R., & Liu, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066611 · Cited by 110
RetractedTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000167407.83915.e7 · Cited by 1,944
Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,104
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Advanced glycoxidation end products in commonly consumed foods
Goldberg, T., Cai, W., Peppa, M., Dardaine, V., Baliga, B. S., Uribarri, J., & Vlassara, H. (2004) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.05.214 · Cited by 744
Self-citationVlassara, H., Cai, W., Crandall, J., Goldberg, T., Oberstein, R., Dardaine, V., Peppa, M., & Rayfield, E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242407999 · Cited by 668
Berenson, G. S., Wattigney, W. A., Tracy, R. E., Newman, W. P., Srinivasan, S. R., Webber, L. S., Dalferes, E. R., & Strong, J. P. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90726-f · Cited by 591
RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice
Bucciarelli, L. G., Wendt, T., Qu, W., Lu, Y., Lalla, E., Rong, L. L., Goova, M. T., Moser, B., Kislinger, T., Lee, D. C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039325.03698.36 · Cited by 563
The RAGE axis: A fundamental mechanism signaling danger to the vulnerable vasculature
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Circulation Research · doi:10.1161/circresaha.109.212217 · Cited by 381
Cai, W., Ramdas, M., Zhu, L., Chen, X., Striker, G. E., & Vlassara, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205847109 · Cited by 325
Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes
Uribarri, J., Cai, W., Ramdas, M., Goodman, S., Pyzik, R., Chen, X., Zhu, L., Striker, G. E., & Vlassara, H. (2011) · Diabetes Care · doi:10.2337/dc11-0091 · Cited by 320
Self-citationHofmann, S. M., Dong, H.-J., Li, Z., Cai, W., Altomonte, J., Thung, S. N., Zeng, F., Fisher, E. A., & Vlassara, H. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2082 · Cited by 296
TODAY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-2393 · Cited by 288
Stirban, A., Negrean, M., Stratmann, B., Gawlowski, T., Horstmann, T., Götting, C., Kleesiek, K., Mueller-Roesel, M., Koschinsky, T., Uribarri, J., et al. (2006) · Diabetes Care · doi:10.2337/dc06-0531 · Cited by 259
Self-citationBirlouez-Aragon, I., Saavedra, G., Tessier, F. J., Galinier, A., Ait-Ameur, L., Lacoste, F., Niamba, C.-N., Alt, N., Somoza, V., & Lecerf, J.-M. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28737 · Cited by 246
Cai, W., Gao, Q.-D., Zhu, L., Peppa, M., He, C., & Vlassara, H. (2002) · Molecular Medicine · doi:10.1007/bf03402014 · Cited by 235
Negrean, M., Stirban, A., Stratmann, B., Gawlowski, T., Horstmann, T., Götting, C., Kleesiek, K., Mueller-Roesel, M., Koschinsky, T., Uribarri, J., et al. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1236 · Cited by 235
Self-citationVlassara, H., Cai, W., Goodman, S., Pyzik, R., Yong, A., Chen, X., Zhu, L., Neade, T., Beeri, M., Silverman, J. M., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0089 · Cited by 226
Self-citationInsulin Resistance and Type 2 Diabetes in High-Fat–Fed Mice Are Linked to High Glycotoxin Intake
Sandu, O., Song, K., Cai, W., Zheng, F., Uribarri, J., & Vlassara, H. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2314 · Cited by 213
Self-citationPrevention of diabetic nephropathy in mice by a diet low in glycoxidation products
Zheng, F., He, C., Cai, W., Hattori, M., Steffes, M., & Vlassara, H. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.283 · Cited by 206
The RAGE Axis in Early Diabetic Retinopathy
Barile, G. R., Pachydaki, S. I., Tari, S. R., Lee, S. E., Donmoyer, C. M., Ma, W., Rong, L. L., Buciarelli, L. G., Wendt, T., Ho¨rig, H., et al. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1409 · Cited by 200
He, C., Sabol, J., Mitsuhashi, T., & Vlassara, H. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1308 · Cited by 191
Hyogo, H., Yamagishi, S., Iwamoto, K., Arihiro, K., Takeuchi, M., Sato, T., Ochi, H., Nonaka, M., Nabeshima, Y., Inoue, M., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04943.x · Cited by 187
RAGE: a novel biological and genetic marker for vascular disease
Kalea, A. Z., Schmidt, A. M., & Hudson, B. I. (2009) · Clinical Science · doi:10.1042/cs20080494 · Cited by 183
Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice
Lin, R.-Y., Choudhury, R. P., Cai, W., Lu, M., Fallon, J. T., Fisher, E. A., & Vlassara, H. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00050-9 · Cited by 171
Unoki‐Kubota, H., Bujo, H., Yamagishi, S., Takeuchi, M., Imaizumi, T., & Saitō, Y. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.09.016 · Cited by 161
Fehrenbach, H., Weiskirchen, R., Kasper, M., & Gressner, A. M. (2001) · Hepatology · doi:10.1053/jhep.2001.28788 · Cited by 154
Uribarri, J., Cai, W., Woodward, M., Tripp, E., Goldberg, L., Pyzik, R., Yee, K., Tansman, L., Chen, X., Mani, V., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3925 · Cited by 152
Self-citationMiele, C., Riboulet, A., Maitan, M. A., Oriente, F., Romano, C., Formisano, P., Giudicelli, J., Bèguinot, F., & OBBERGHEN, E. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301088200 · Cited by 141
Soluble form of a receptor for advanced glycation end products sRAGE as a biomarker
Yamagishi, S., & Matsui, T. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e178 · Cited by 134
Fetal or Neonatal Low-Glycotoxin Environment Prevents Autoimmune Diabetes in NOD Mice
Peppa, Μ., He, C., Hattori, M., McEvoy, R. C., Zheng, F., & Vlassara, H. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1441 · Cited by 133
Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease
Hyogo, H., & Yamagishi, S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784139701 · Cited by 129
Cai, W., He, C., Zhu, L., Chen, X., Striker, G. E., & Vlassara, H. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00350.2007 · Cited by 118
Lin, R.-Y., Reis, E. D., Dore, A. T., Lu, M., Ghodsi, N., Fallon, J. T., Fisher, E. A., & Vlassara, H. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00008-4 · Cited by 109
Advanced glycation end-products induce injury to pancreatic beta cells through oxidative stress
Lin, N., Zhang, H., & Su, Q. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.01.003 · Cited by 103
Plasma advanced glycation end products are decreased in obese children compared with lean controls
Šebeková, K., Somoza, V., Jarčušková, M., Heidland, A., & Podracká, L. (2009) · International Journal of Pediatric Obesity · doi:10.1080/17477160802248039 · Cited by 82
Maternally Transmitted and Food-Derived Glycotoxins
Mericq, V., Piccardo, C., Cai, W., Chen, X., Zhu, L., Striker, G. E., Vlassara, H., & Uribarri, J. (2010) · Diabetes Care · doi:10.2337/dc10-1058 · Cited by 82
Self-citationGlycotoxin and Autoantibodies Are Additive Environmentally Determined Predictors of Type 1 Diabetes
Beyan, H., Riese, H., Hawa, M. I., Beretta, G., Davidson, H. W., Hutton, J. C., Burger, H., Schlosser, M., Snieder, H., Boehm, B. O., et al. (2012) · Diabetes · doi:10.2337/db11-0971 · Cited by 62
Klenovics, K. S., Boor, P., Somoza, V., Celec, P., Fogliano, V., & Šebeková, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053056 · Cited by 52
Effects of a diet rich in advanced glycation end products in the rat remnant kidney model
Šebeková, K., Faist, V., Hofmann, T. F., Schinzel, R., & Heidland, A. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50084 · Cited by 52
D’Adamo, E., Giannini, C., Chiavaroli, V., de Giorgis, T., Verrotti, A., Chiarelli, F., & Mohn, A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3719 · Cited by 50
Hansen, B., Svistounov, D., Olsen, R. F., Nagai, R., Horiuchi, S., & d, B. S. X. F. (2002) · Diabetologia · doi:10.1007/s00125-002-0912-8 · Cited by 48
D’Adamo, E., Marcovecchio, M. L., Giannini, C., de Giorgis, T., Chiavaroli, V., Chiarelli, F., & Mohn, A. (2012) · Free Radical Research · doi:10.3109/10715762.2012.755262 · Cited by 44
Glycated fetal calf serum affects the viability of an insulin-secreting cell line in vitro
Viviani, G. L., Puddu, A., Sacchi, G., Garuti, A., Storace, D., Durante, A., Monacelli, F., & Odetti, P. R. (2008) · Metabolism · doi:10.1016/j.metabol.2007.08.020 · Cited by 42
Baldi, J. C., Manning, P. J., Hofman, P. L., & Walker, R. J. (2013) · Diabetes Care · doi:10.2337/dc13-1426 · Cited by 39
Accacha, S. D., Rosenfeld, W., Jacobson, A., Michel, L., Schnurr, F. J., Shelov, S. P., Ten, S., Boucher‐Berry, C., Carey, D. E., Speiser, P., et al. (2013) · Hormone Research in Paediatrics · doi:10.1159/000354831 · Cited by 33
Wu, J. C., Li, X. H., Peng, Y., Wang, J. B., Tang, J. F., & Wang, Y. F. (2011) · PubMed · doi:10.3275/7856 · Cited by 27
Puddu, A., Storace, D., Durante, A., Odetti, P. R., & Viviani, G. L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.100 · Cited by 26
Chiavaroli, V., D’Adamo, E., Giannini, C., de Giorgis, T., Marco, S. D., Chiarelli, F., & Mohn, A. (2012) · Diabetes Care · doi:10.2337/dc11-2302 · Cited by 26
Boor, P., Celec, P., Klenovicsová, K., Vlková, B., Szemes, T., Minárik, G., Turňa, J., & Šebeková, K. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.03.033 · Cited by 14
Research works printed but not linked: 1
- 10.1089/ars.2012.4525 · doi:10.1089/ars.2012.4525
Cited by
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Metadata
- Authors
- Gupta, A., & Uribarri, J.
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 85
- Issue
- 5
- Pages
- 291-300
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2302447233
- Cited by
- 4,006
- References
- 53
- FWCI
- 322.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.